China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) — Cash Flow Reinvestment Rate
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a Cash Flow Reinvestment Rate of 2.38x as of September 2025, reinvesting CN¥302.02 Million (capex CN¥302.02 Million ) from operating cash flow of CN¥126.71 Million. Check China Resources Sanjiu Medical & Pharmac cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2024)
Historical reinvestment intensity for China Resources Sanjiu Medical & Pharmaceutical Co Ltd across 25 annual periods. Explore how much of China Resources Sanjiu Medical & Pharmac's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1999–2024)
Year-by-year capital reinvestment analysis for China Resources Sanjiu Medical & Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 000999 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.24x | CN¥1.04 Billion | CN¥4.40 Billion | CN¥790.07 Million | ▼ -39.9% |
| 2023 | 0.39x | CN¥1.65 Billion | CN¥4.22 Billion | CN¥857.21 Million | ▼ -65.7% |
| 2022 | 1.14x | CN¥3.43 Billion | CN¥3.01 Billion | CN¥951.57 Million | ▲ +22.6% |
| 2021 | 0.93x | CN¥1.74 Billion | CN¥1.87 Billion | CN¥870.80 Million | ▲ +47.4% |
| 2020 | 0.63x | CN¥1.40 Billion | CN¥2.22 Billion | CN¥621.82 Million | ▲ +89.3% |
| 2019 | 0.33x | CN¥657.49 Million | CN¥1.97 Billion | CN¥535.97 Million | ▼ -22.3% |
| 2018 | 0.43x | CN¥820.07 Million | CN¥1.91 Billion | CN¥600.36 Million | ▼ -13.6% |
| 2017 | 0.50x | CN¥774.84 Million | CN¥1.56 Billion | CN¥374.74 Million | ▼ -56.2% |
| 2016 | 1.13x | CN¥1.58 Billion | CN¥1.39 Billion | CN¥354.33 Million | ▲ +58.3% |
| 2015 | 0.72x | CN¥902.16 Million | CN¥1.26 Billion | CN¥330.65 Million | ▲ +148.6% |
| 2014 | 0.29x | CN¥341.22 Million | CN¥1.18 Billion | CN¥341.22 Million | ▲ +19.1% |
| 2013 | 0.24x | CN¥354.89 Million | CN¥1.47 Billion | CN¥354.89 Million | ▼ -41.9% |
| 2012 | 0.42x | CN¥504.52 Million | CN¥1.21 Billion | CN¥504.52 Million | ▼ -3.0% |
| 2011 | 0.43x | CN¥409.79 Million | CN¥954.90 Million | CN¥409.79 Million | ▲ +34.8% |
| 2010 | 0.32x | CN¥270.00 Million | CN¥848.28 Million | CN¥270.00 Million | ▲ +41.1% |
| 2009 | 0.23x | CN¥192.93 Million | CN¥855.05 Million | CN¥192.93 Million | ▼ -79.1% |
| 2008 | 1.08x | CN¥1.20 Billion | CN¥1.12 Billion | CN¥1.20 Billion | ▲ +187.7% |
| 2007 | 0.37x | CN¥226.78 Million | CN¥605.30 Million | CN¥226.78 Million | ▲ +17.4% |
| 2006 | 0.32x | CN¥135.81 Million | CN¥425.51 Million | CN¥135.81 Million | ▼ -80.4% |
| 2005 | 1.63x | CN¥37.14 Million | CN¥22.83 Million | CN¥37.14 Million | ▼ -66.4% |
| 2003 | 4.84x | CN¥135.88 Million | CN¥28.09 Million | CN¥135.88 Million | ▲ +1289.6% |
| 2002 | 0.35x | CN¥172.67 Million | CN¥496.12 Million | CN¥172.67 Million | ▼ -55.1% |
| 2001 | 0.77x | CN¥118.83 Million | CN¥153.44 Million | CN¥118.83 Million | ▲ +21.2% |
| 2000 | 0.64x | CN¥170.58 Million | CN¥266.86 Million | CN¥170.58 Million | ▲ +5.0% |
| 1999 | 0.61x | CN¥73.43 Million | CN¥120.63 Million | CN¥73.43 Million | — |